Search Results - "Cancer"
Suggested Topics within your search.
Suggested Topics within your search.
- Antibodies, Monoclonal
- therapeutic use 10
- Immunotherapy 8
- drug therapy 7
- Neoplasms 6
- immunology 6
- therapy 6
- Antineoplastic Agents 5
- Antineoplastic agents 5
- Cancer 5
- Monoclonal antibodies 4
- Antigens, Neoplasm 3
- Antineoplastic Agents, Immunological 3
- Cell Cycle Checkpoints 3
- Chemotherapy 3
- Immunoconjugates 3
- T-Lymphocytes 3
- pharmacology 3
- trends 3
- Antibody-drug conjugates 2
- CTLA-4 Antigen 2
- Cancer Vaccines 2
- Clinical Trials as Topic 2
- Immunological aspects 2
- Immunotoxins 2
- Oncogenes 2
- T cells 2
- Therapeutic use 2
- Tumor antigens 2
- antagonists & inhibitors 2
-
1
Cancer immunotherapy
Published 2021Subjects: “…Cancer Immunotherapy. 84884…”
Get full text
Series (Immune system)
Series (Molecular basis of cancer)
Electronic Video -
2
-
3
Human tumor antigens as therapeutic targets of cancer
Published 2015Table of Contents: “…Contents: Products of oncogenes as therapeutic targets -- Differentiation antigens as therapeutic targets -- Angiogenesis associated antigens as therapeutic targets -- Endoglin-targeted cancer therapy.…”
Get full text
Series
Electronic Video -
4
Monoclonal antibodies and the ErbB system in human cancer
Published 2019Table of Contents: “…Contents: General properties of tumor cells -- Human breast cancer and the erbB2/neu oncogene and protein -- Targeted monoclonal antibodies -- Tyrosine kinase activity and dimerization -- Activation of the kinase of erbB2/neu -- Overexpression of erbB2/neu and EGFr -- The erbB family members -- Discussion of Herceptin -- Prevention of tumor growth in a neoadjuvant model -- Two antibody therapy & tumor growth inhibition.…”
Get full text
Series
Electronic Video -
5
Anti-IL-2 receptor antibodies as models for cancer therapy
Published 2007Get full text
Series
Electronic Video -
6
Immune checkpoint blockade in renal cell carcinoma
Published 2016Subjects: Get full text
Series (Immunotherapy of cancer)
Series (Kidney in health and disease)
Electronic Video -
7
The development of therapeutic antibodies against oncogenic antigens
Published 2020Subjects: Get full text
Series
Electronic Audio -
8
The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /
Published 2019Subjects: Get full text
Electronic Video -
9
Immune checkpoint blockade in melanoma
Published 2017Table of Contents: “…Contents: Checkpoint inhibition in melanoma -- Immunotherapy in the adjuvant setting -- Biomarkers of immune response -- The future of immunotherapy in melanoma -- Targeting release of cancer antigens -- Targeting cancer antigen presentation -- Targeting priming and activation of the immune system -- Targeting trafficking and infiltration of T-cells -- Targeting recognition and killing of cancer cells.…”
Get full text
Series
Electronic Video -
10
Therapeutic antibodies
Published 2020Table of Contents: “…Contents: Why antibodies are so useful as drugs -- Antibody therapy -- The development of monoclonal antibodies -- Genetic engineering -- The problem of unwanted immunogenicity -- The importance of affinity -- Examples of antibodies for treatment of cancer -- Examples of antibodies for treatment of immunological diseases.…”
Get full text
Series
Electronic Video -
11
The challenge of targeting toxins to tumors
Published 2007Table of Contents: “…Contents: Generation of immunotoxins -- Mode of action of different immunotoxins -- Strategies to overcome the major impediments in the therapeutic application of immunotoxins to cancer patients -- Anti-endoglin monoclonal antibodies and immunotoxins -- Anti-angiogenic therapy of tumors -- Vascular targeting therapy of tumors -- Comparison between immunotoxins and naked antibodies in therapeutic application.…”
Get full text
Series
Electronic Video -
12
Monoclonal antibodies in haemato-oncology
Published 2020Table of Contents: “…Contents: Introduction to the development and clinical use of monoclonal antibodies (mAb) in haemato-oncology -- Currently approved mAb for treating cancer -- Direct targeting antibodies -- Rituximab -- Fc gamma receptors (FcgR) as key mediators of cellular immunity -- Macrophages as key effector cells -- B cell deletion as a paradigm for mAb effects -- Type I versus Type II antibodies -- Obinutuzumab -- Immunomodulatory mAb -- Combinations between direct targeting and immunomodulatory mAb.…”
Get full text
Series (Monoclonal antibodies as therapeutic agents)
Series (Immune system)
Electronic Video